The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Feasibility of risk stratified allocation to single versus tandem autologous SCT in multiple myeloma.
Matthew Risendal
No relevant relationships to disclose
Allison Hazlett
No relevant relationships to disclose
Roy T. Sabo
No relevant relationships to disclose
Priscilla Mpasi
No relevant relationships to disclose
Joan Bolling
No relevant relationships to disclose
William B. Clark
No relevant relationships to disclose
John McCarty
No relevant relationships to disclose
Harold M. Chung
No relevant relationships to disclose
Catherine H. Roberts
No relevant relationships to disclose
Amir A. Toor
No relevant relationships to disclose